You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

You’ve been redirected to the new Cancer Care Ontario website. You can also visit the archived website, which is no longer being maintained.

Chemotherapy for Relapsed Small Cell Lung Cancer

Version: 2 ID: 7-17 May 2013
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
S. Cheng, W.K. Evans, D. Stys-Norman, F.A. Shepherd, Lung Cancer Disease Site Group

Patient Population

Adult patients with relapsed SCLC.

Research Question(s)

  1. In patients with relapsed small cell lung cancer (SCLC), does chemotherapy improve survival and quality of life?
  2. Which single-agent or combination chemotherapy regimen is most effective in the treatment of relapsed SCLC?
  3. Which patients with relapsed SCLC are most likely to benefit from additional chemotherapy?
pdf download Summary (PDF) (205.95 KB)
pdf download Full Report (PDF) (636.33 KB)